No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA)
Document Type
Journal Article
Publication Date
12-2020
Journal
Maturitas
Volume
142
Inclusive Pages
38-44
DOI
10.1016/j.maturitas.2020.06.021
APA Citation
Cai, B., Simon, J., Villa, P., Biglia, N., Panay, N., Djumaeva, S., Particco, M., Kanakamedala, H., & Altomare, C. (2020). No increase in incidence or risk of recurrence of breast cancer in ospemifene-treated patients with vulvovaginal atrophy (VVA). Maturitas, 142 (). http://dx.doi.org/10.1016/j.maturitas.2020.06.021
Peer Reviewed
1